Literature DB >> 23032186

A20 inhibits LUBAC-mediated NF-κB activation by binding linear polyubiquitin chains via its zinc finger 7.

Kelly Verhelst1, Isabelle Carpentier, Marja Kreike, Laura Meloni, Lynn Verstrepen, Tobias Kensche, Ivan Dikic, Rudi Beyaert.   

Abstract

Linear polyubiquitination of proteins has recently been implicated in NF-κB signalling and is mediated by the linear ubiquitin chain assembly complex (LUBAC), consisting of HOIL-1, HOIP and Sharpin. However, the mechanisms that regulate linear ubiquitination are still unknown. Here, we show that A20 is rapidly recruited to NEMO and LUBAC upon TNF stimulation and that A20 inhibits LUBAC-induced NF-κB activation via its C-terminal zinc-finger 7 (ZF7) domain. Expression of a polypeptide corresponding to only ZF7 was sufficient to inhibit TNF-induced NF-κB activation. Both A20 and ZF7 can form a complex with NEMO and LUBAC, and are able to prevent the TNF-induced binding of NEMO to LUBAC. Finally, we show that ZF7 preferentially binds linear polyubiquitin chains in vitro, indicating A20-ZF7 as a novel linear ubiquitin-binding domain (LUBID). We thus propose a model in which A20 inhibits TNF- and LUBAC-induced NF-κB signalling by binding to linear polyubiquitin chains via its seventh zinc finger, which prevents the TNF-induced interaction between LUBAC and NEMO.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23032186      PMCID: PMC3463847          DOI: 10.1038/emboj.2012.240

Source DB:  PubMed          Journal:  EMBO J        ISSN: 0261-4189            Impact factor:   11.598


  40 in total

1.  Ubiquitin binding to A20 ZnF4 is required for modulation of NF-κB signaling.

Authors:  Ivan Bosanac; Ingrid E Wertz; Borlan Pan; Christine Yu; Saritha Kusam; Cynthia Lam; Lilian Phu; Qui Phung; Brigitte Maurer; David Arnott; Donald S Kirkpatrick; Vishva M Dixit; Sarah G Hymowitz
Journal:  Mol Cell       Date:  2010-11-24       Impact factor: 17.970

2.  Recruitment of the linear ubiquitin chain assembly complex stabilizes the TNF-R1 signaling complex and is required for TNF-mediated gene induction.

Authors:  Tobias L Haas; Christoph H Emmerich; Björn Gerlach; Anna C Schmukle; Stefanie M Cordier; Eva Rieser; Rebecca Feltham; James Vince; Uwe Warnken; Till Wenger; Ronald Koschny; David Komander; John Silke; Henning Walczak
Journal:  Mol Cell       Date:  2009-12-11       Impact factor: 17.970

3.  A20 deficiency in B cells enhances B-cell proliferation and results in the development of autoantibodies.

Authors:  Nadine Hövelmeyer; Sonja Reissig; Nguyen Thi Xuan; Petra Adams-Quack; Dominika Lukas; Alexei Nikolaev; Dirk Schlüter; Ari Waisman
Journal:  Eur J Immunol       Date:  2011-02-10       Impact factor: 5.532

4.  SHARPIN is a component of the NF-κB-activating linear ubiquitin chain assembly complex.

Authors:  Fuminori Tokunaga; Tomoko Nakagawa; Masaki Nakahara; Yasushi Saeki; Masami Taniguchi; Shin-ichi Sakata; Keiji Tanaka; Hiroyasu Nakano; Kazuhiro Iwai
Journal:  Nature       Date:  2011-03-31       Impact factor: 49.962

5.  Linear ubiquitination prevents inflammation and regulates immune signalling.

Authors:  Björn Gerlach; Stefanie M Cordier; Anna C Schmukle; Christoph H Emmerich; Eva Rieser; Tobias L Haas; Andrew I Webb; James A Rickard; Holly Anderton; Wendy W-L Wong; Ueli Nachbur; Lahiru Gangoda; Uwe Warnken; Anthony W Purcell; John Silke; Henning Walczak
Journal:  Nature       Date:  2011-03-31       Impact factor: 49.962

6.  SHARPIN forms a linear ubiquitin ligase complex regulating NF-κB activity and apoptosis.

Authors:  Fumiyo Ikeda; Yonathan Lissanu Deribe; Sigrid S Skånland; Benjamin Stieglitz; Caroline Grabbe; Mirita Franz-Wachtel; Sjoerd J L van Wijk; Panchali Goswami; Vanja Nagy; Janos Terzic; Fuminori Tokunaga; Ariadne Androulidaki; Tomoko Nakagawa; Manolis Pasparakis; Kazuhiro Iwai; John P Sundberg; Liliana Schaefer; Katrin Rittinger; Boris Macek; Ivan Dikic
Journal:  Nature       Date:  2011-03-31       Impact factor: 49.962

7.  The ubiquitin modifying enzyme A20 restricts B cell survival and prevents autoimmunity.

Authors:  Rita M Tavares; Emre E Turer; Chih L Liu; Rommel Advincula; Patrizia Scapini; Lesley Rhee; Julio Barrera; Clifford A Lowell; Paul J Utz; Barbara A Malynn; Averil Ma
Journal:  Immunity       Date:  2010-08-12       Impact factor: 31.745

8.  B cells lacking the tumor suppressor TNFAIP3/A20 display impaired differentiation and hyperactivation and cause inflammation and autoimmunity in aged mice.

Authors:  Yuanyuan Chu; J Christoph Vahl; Dilip Kumar; Klaus Heger; Arianna Bertossi; Edyta Wójtowicz; Valeria Soberon; Dominik Schenten; Brigitte Mack; Miriam Reutelshöfer; Rudi Beyaert; Kerstin Amann; Geert van Loo; Marc Schmidt-Supprian
Journal:  Blood       Date:  2010-11-18       Impact factor: 22.113

9.  Enterocyte-specific A20 deficiency sensitizes to tumor necrosis factor-induced toxicity and experimental colitis.

Authors:  Lars Vereecke; Mozes Sze; Conor Mc Guire; Brecht Rogiers; Yuanyuan Chu; Marc Schmidt-Supprian; Manolis Pasparakis; Rudi Beyaert; Geert van Loo
Journal:  J Exp Med       Date:  2010-06-07       Impact factor: 14.307

10.  A ubiquitin replacement strategy in human cells reveals distinct mechanisms of IKK activation by TNFalpha and IL-1beta.

Authors:  Ming Xu; Brian Skaug; Wenwen Zeng; Zhijian J Chen
Journal:  Mol Cell       Date:  2009-10-23       Impact factor: 17.970

View more
  97 in total

1.  A20 targets caspase-8 and FADD to protect HTLV-I-infected cells.

Authors:  Y Saitoh; A Hamano; K Mochida; A Kakeya; M Uno; E Tsuruyama; H Ichikawa; F Tokunaga; A Utsunomiya; T Watanabe; S Yamaoka
Journal:  Leukemia       Date:  2015-10-06       Impact factor: 11.528

Review 2.  Necroptosis: A new way of dying?

Authors:  Britt Hanson
Journal:  Cancer Biol Ther       Date:  2016-07-19       Impact factor: 4.742

3.  A20 suppresses vascular inflammation by recruiting proinflammatory signaling molecules to intracellular aggresomes.

Authors:  Karine Enesa; Herwig P Moll; Le Luong; Christiane Ferran; Paul C Evans
Journal:  FASEB J       Date:  2015-02-09       Impact factor: 5.191

Review 4.  TNF biology, pathogenic mechanisms and emerging therapeutic strategies.

Authors:  George D Kalliolias; Lionel B Ivashkiv
Journal:  Nat Rev Rheumatol       Date:  2015-12-10       Impact factor: 20.543

Review 5.  Regulation of tumour necrosis factor signalling: live or let die.

Authors:  Dirk Brenner; Heiko Blaser; Tak W Mak
Journal:  Nat Rev Immunol       Date:  2015-06       Impact factor: 53.106

Review 6.  An Update on Autoinflammatory Diseases: Relopathies.

Authors:  Annemarie Steiner; Cassandra R Harapas; Seth L Masters; Sophia Davidson
Journal:  Curr Rheumatol Rep       Date:  2018-05-30       Impact factor: 4.592

Review 7.  Regulation of nuclear factor-κB in autoimmunity.

Authors:  Shao-Cong Sun; Jae-Hoon Chang; Jin Jin
Journal:  Trends Immunol       Date:  2013-02-20       Impact factor: 16.687

Review 8.  Regulation of NF-κB by TNF family cytokines.

Authors:  Matthew S Hayden; Sankar Ghosh
Journal:  Semin Immunol       Date:  2014-06-21       Impact factor: 11.130

Review 9.  Linear ubiquitin chains: NF-κB signalling, cell death and beyond.

Authors:  Kazuhiro Iwai; Hiroaki Fujita; Yoshiteru Sasaki
Journal:  Nat Rev Mol Cell Biol       Date:  2014-07-09       Impact factor: 94.444

Review 10.  RBR E3-ligases at work.

Authors:  Judith J Smit; Titia K Sixma
Journal:  EMBO Rep       Date:  2014-01-27       Impact factor: 8.807

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.